Vigilare Wealth Management Oncternal Therapeutics, Inc. Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 06, 2022	SELL	$1.37 - $2.43 $67,575 - $119,859	-49,325 Closed	0 $0
Q4 2021 Jan 07, 2022	SELL	$2.27 - $4.39 $32,086 - $62,052	-14,135 Reduced 22.27%	49,325 $112,000
Q3 2021 Oct 19, 2021	BUY	$3.37 - $4.76 $36,817 - $52,003	10,925 Added 20.8%	63,460 $265,000
Q2 2021 Jul 16, 2021	BUY	$4.75 - $9.39 $99,797 - $197,283	21,010 Added 66.65%	52,535 $250,000
Q1 2021 Apr 29, 2021	BUY	$4.59 - $9.04 $41,424 - $81,585	9,025 Added 40.11%	31,525 $262,000

Q4 2020 Jan 14, 2021	BUY	$1.51 - $6.3 $33,975 - $141,750	22,500 New	22,500 $110,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $391M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.